Table 2.
Demographic and clinical data in all group and in subgroups with and without persistently elevated PSA levels.
| Parameter | All n = 118 |
Postoperative PSA < 0.1 ng/mL (n = 97) |
Postoperative PSA > 0.1 ng/mL (n = 21) |
d-Cohen | p | |
|---|---|---|---|---|---|---|
| Age (y) | 66.0 (60–70) |
66.0 (60.0–70.0) |
67.0 (65.0–71.0) |
0.82 | 0.29 | |
| BMI (kg/m2) | 27.2 (25.6–29.7) |
26.8 (25.4–29.7) |
27.5 (26.0–29.0) |
0.16 | 0.54 | |
| Months from surgery (m) | 19.0 (13.0–33.0) |
19.0 (14.0–33.0) |
23.0 (12.0–33.0) |
0.03 | 0.70 | |
| Diabetes (n, %) | 19 (16%) | 14 (14.5%) | 5 (24%) | 0.50 | ||
| Hypertension (n, %) | 65 (55%) | 59 (61%) | 6 (28.5%) | 0.02 | ||
| MI (n, %) | 10 (8.5%) | 8 (8%) | 2 (9.5%) | 0.92 | ||
| Stroke (n, %) | 7 (6%) | 7 (7%) | 0 (0%) | 0.60 | ||
| Education | Basic (n, %) | 6 (5%) | 5 (5%) | 1 (5%) | 0.31 | |
| Vocational (n, %) | 33 (28%) | 27 (28%) | 6 (28.5%) | |||
| Secondary (n, %) | 36 (30.5%) | 26 (27%) | 10 (47.5%) | |||
| Higher (n, %) | 43 (36.5%) | 39 (40%) | 4 (19%) | |||
| Physical activity | None (n, %) | 40 (34%) | 37 (38%) | 3 (14%) | 0.09 | |
| <1x/week (n, %) | 24 (20.5%) | 17 (17.5%) | 7 (33.5%) | |||
| <3x/week | 54 (45.5%) | 43 (44.5%) | 11 (52.5%) | |||
| GRADE | 1 (n, %) | 70 (59.5%) | 63 (65%) | 7 (33.5%) | 0.005 | |
| 2 (n, %) | 35 (29.5%) | 27 (28%) | 8 (38%) | |||
| 3 (n, %) | 5 (4%) | 5 (5%) | 0 (0.0%) | |||
| 4 (n, %) | 4 (3.5%) | 1 (1%) | 3 (14.25%) | |||
| 5 (n, %) | 4 (3.5%) | 1 (1%) | 3 (14.25%) | |||
| Nicotinism (n, %) | 53 (45%) | 44 (45%) | 9 (43%) | 0.86 | ||
Data are shown as the median (Q25–Q75) or number (%). Inter-group differences were assessed using the Mann–Whitney U test. Effect size was measured using the Cohen d method. BMI—body mass index; MI—myocardial infarction; GRADE: group of grading system classification; y—years; m—months. Significant p-values shown in bold.